Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × defactinib × 30 days × Clear all

Phase

Phase 2 2 Phase 1 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Low Grade Serous Ovarian Cancer 1

Interventions

pembrolizumab 79 Carboplatin 65 Cisplatin 62 Paclitaxel 52 Specimen Handling 50 Magnetic Resonance Spectroscopy 49 Gemcitabine 47 Docetaxel 36 Cyclophosphamide 36 Pemetrexed 32 Dexamethasone 31 Fluorouracil 30 Doxorubicin 30 Bevacizumab 30 Radiotherapy 28 Capecitabine 28 durvalumab 27 Oxaliplatin 27 Radiation 26 Rituximab 24 Leucovorin 24 Lenalidomide 23 Vincristine 22 Nivolumab 19 Irinotecan 18 130-nm albumin-bound paclitaxel 18 venetoclax 17 Prednisone 17 Taxes 16 Letrozole 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06072781 2026-03-17

RAMP 301

Verastem, Inc.

Phase 3 Recruiting

Low Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡